85 related articles for article (PubMed ID: 7454709)
1. [Effect of teralen on brain bioelectrical activity in Itsenko-Cushing disease and hypothalamic syndrome patients].
Frenkel' GM; Butrova SA
Probl Endokrinol (Mosk); 1980; 26(6):22-5. PubMed ID: 7454709
[TBL] [Abstract][Full Text] [Related]
2. [Effect of L-DOPA administration on brain bioelectrical activity in hypothalamo-hypophyseal diseases].
Safronova NA; Frenkel' GM; Marova EI
Probl Endokrinol (Mosk); 1978; 24(2):13-7. PubMed ID: 347432
[TBL] [Abstract][Full Text] [Related]
3. [Neurotensin in Itsenko-Cushing disease].
Slavnov VN; Luchitskiĭ EV; Iakovlev AA; Komissarenko IV; Valueva GV
Probl Endokrinol (Mosk); 1984; 30(4):35-40. PubMed ID: 6382246
[TBL] [Abstract][Full Text] [Related]
4. [The importance of immunogenetic studies in Itsenko-Cushing disease combined with other endocrine diseases].
Kalinin AP; Andrusenko AB; Zaretskaia IuM; Abramov VIu; Klinova EG; Bogatyrev OP; Donskov SI; Manishkina RP
Ter Arkh; 1992; 64(2):103-8. PubMed ID: 1509359
[TBL] [Abstract][Full Text] [Related]
5. [Myocardial contractile function in Itsenko-Cushing disease].
Dimova MN
Probl Endokrinol (Mosk); 1977; 23(6):5-9. PubMed ID: 600929
[TBL] [Abstract][Full Text] [Related]
6. [Various mechanisms of disorders of the hypothalamo-hypophyseal-adrenal system in Cushing's syndrome].
Slavnov VN; Luchitskiĭ EV; Komissarenko IV; Cheban AK
Probl Endokrinol (Mosk); 1978; 24(1):30-5. PubMed ID: 204919
[TBL] [Abstract][Full Text] [Related]
7. [The functional condition of blood-brain barrier in Itsenko-Cushing's disease and diencephalic syndrome of Itsenko-Cushing's disease].
Gincherman EZ; Balakhovskaia MI
Probl Endokrinol (Mosk); 1968; 14(4):43-8. PubMed ID: 5734178
[No Abstract] [Full Text] [Related]
8. [The HLA system and Itsenko-Cushing disease].
Manishkina RP; Andrusenko AB; Donskov SI; Kalinin AP; Klinova EG
Ter Arkh; 1984; 56(8):133-5. PubMed ID: 6333733
[TBL] [Abstract][Full Text] [Related]
9. Profound amplification of secretory-burst mass and anomalous regularity of ACTH secretory process in patients with Nelson's syndrome compared with Cushing's disease.
van Aken MO; Pereira AM; van den Berg G; Romijn JA; Veldhuis JD; Roelfsema F
Clin Endocrinol (Oxf); 2004 Jun; 60(6):765-72. PubMed ID: 15163342
[TBL] [Abstract][Full Text] [Related]
10. [Pathogenesis of the arterial hypertensive syndrome in Itsenko-Cushing disease].
Komissarenko IV; Slavnov VN; Cheban AK; Iakovlev AA; Demchenko NP
Probl Endokrinol (Mosk); 1982; 28(6):28-31. PubMed ID: 6296809
[TBL] [Abstract][Full Text] [Related]
11. [Blood plasma content of thyroxine and thyrotropic hormone in Cushing's syndrome and juvenile dyspituitarism syndrome].
Aleksandrova GF
Probl Endokrinol (Mosk); 1977; 23(1):39-42. PubMed ID: 846975
[TBL] [Abstract][Full Text] [Related]
12. [Alpha-tocopherol concentration of the blood plasma and erythrocytes in patients with symptomatic obesity due to hypothalamo-hypophyseal-adrenal diseases].
Tishenina RS
Probl Endokrinol (Mosk); 1986; 32(4):25-30. PubMed ID: 3763569
[TBL] [Abstract][Full Text] [Related]
13. [Indices of the functional state of the thyroid gland in Itsenko-Cushing's disease].
Shtegeman NA; Kalinin AP
Sov Med; 1972 Jun; 35(6):79-82. PubMed ID: 4127765
[No Abstract] [Full Text] [Related]
14. Effect of the antiserotonin drug, cyproheptadine, on plasma beta-endorphin and beta-lipotropin in patients with Itsenko-Cushing's disease.
Slavnov VN; Valueva GV; Luchitsky EV
Exp Clin Endocrinol; 1985 Jun; 85(3):341-50. PubMed ID: 2995088
[TBL] [Abstract][Full Text] [Related]
15. [Glucose tolerance and manifested diabetes mellitus in patients with Itsenko-Cushing's syndrome].
Galiullin FL
Probl Endokrinol (Mosk); 1971; 17(3):23-7. PubMed ID: 5138405
[No Abstract] [Full Text] [Related]
16. Adrenocorticotropin- and cortisol-releasing effect of hexarelin, a synthetic growth hormone-releasing peptide, in normal subjects and patients with Cushing's syndrome.
Ghigo E; Arvat E; Ramunni J; Colao A; Gianotti L; Deghenghi R; Lombardi G; Camanni F
J Clin Endocrinol Metab; 1997 Aug; 82(8):2439-44. PubMed ID: 9253314
[TBL] [Abstract][Full Text] [Related]
17. [Mechanism of the development of neuromuscular disorders in Itsenko-Cushing disease].
Agafonov BV; Lahutina TS; Deianova AF
Probl Endokrinol (Mosk); 1982; 28(6):22-6. PubMed ID: 7156070
[TBL] [Abstract][Full Text] [Related]
18. [Similarity and differences of the pathogenesis of Itsenko-Cushing syndrome variants].
Baranov VG; Nechaĭ AI; Trofimov VM; Savushkina AS; Kalashnikov SA
Probl Endokrinol (Mosk); 1986; 32(6):3-11. PubMed ID: 3027692
[TBL] [Abstract][Full Text] [Related]
19. [Changes in the cerebral electrical activity of Itsenko-Cushing disease patients under the influence of diphenine].
Frenkel' GM; Safronova NA; Marova EI; Lemesheva SN
Probl Endokrinol (Mosk); 1976; 22(1):19-22. PubMed ID: 1257213
[TBL] [Abstract][Full Text] [Related]
20. [Treatment of Cushing's syndrome with large doses of reserpine].
Andreeva MKh; Bozadzhieva EK; Platonova ES; Zografski SG; Mendizov IKh
Probl Endokrinol (Mosk); 1983; 29(2):39-44. PubMed ID: 6856595
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
